ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NAMS NewAmsterdam Pharma Company NV

23.37
-0.21 (-0.89%)
15 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)
Total Assets 0347.1M488.46M446.69M439.19M864.62M
Total Current Assets 0346.79M487.82M445.35M437.87M863.41M
Cash and Equivalents 0340.45M481.15M430.71M422.73M771.74M
Total Non-Current Assets 0306k641k1.34M1.32M1.21M
Total Liabilities 058.7M76.66M59.25M60.33M107.12M
Total Current Liabilities 049.9M59.73M45.31M41.26M106.92M
Total Non-Current Liabilities 08.81M16.93M13.94M19.07M202k
Common Equity 010.17M11.11M11.15M11.44M13.44M
Retained Earnings 0-316.97M-410.74M-449.75M-466.39M-558.57M
Year End 31 December 2024 20232024
USD (US$)USD (US$)
Total Assets 347.1M864.62M
Total Current Assets 346.79M863.41M
Cash and Equivalents 340.45M771.74M
Total Non-Current Assets 288.39M757.5M
Total Liabilities 58.7M107.12M
Total Current Liabilities 49.9M106.92M
Total Non-Current Liabilities 8.81M202k
Total Equity 288.39M757.5M
Common Equity 10.17M13.44M
Retained Earnings -316.97M-558.57M